We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$10.9B
AUM Growth
+$1.55B
Cap. Flow
+$431M
Cap. Flow %
3.95%
Top 10 Hldgs %
31.03%
Holding
358
New
19
Increased
175
Reduced
113
Closed
11

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$69.5M
2
CMCSA icon
Comcast
CMCSA
+$57.3M
3
ADP icon
Automatic Data Processing
ADP
+$50.3M
4
SPG icon
Simon Property Group
SPG
+$47.8M
5
KO icon
Coca-Cola
KO
+$42.8M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$99.3M
2
AMGN icon
Amgen
AMGN
+$63.5M
3
MKC icon
McCormick & Company Non-Voting
MKC
+$44.1M
4
MO icon
Altria Group
MO
+$37.2M
5
ABT icon
Abbott
ABT
+$24.9M

Sector Composition

Rank Sector Weight
1 Technology 20.61%
2 Healthcare 14.46%
3 Financials 13.86%
4 Industrials 10.4%
5 Consumer Staples 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLOG
176
DELISTED
GASLOG LTD
GLOG
$3.03M 0.03%
173,606
-111,478
-39% -$1.94M
MLAB icon
177
Mesa Laboratories
MLAB
$565M
$3.03M 0.03%
13,146
+313
+2% +$70.7K
KMB icon
178
Kimberly-Clark
KMB
$36.1B
$2.99M 0.03%
24,141
-1,685
-7% -$196K
USPH icon
179
US Physical Therapy
USPH
$1.16B
$2.96M 0.03%
28,168
+805
+3% +$86.5K
RBA icon
180
RB Global
RBA
$17.2B
$2.94M 0.03%
86,438
+2,262
+3% +$79.7K
MDSO
181
DELISTED
Medidata Solutions, Inc.
MDSO
$2.89M 0.03%
39,498
+932
+2% +$67.3K
SON icon
182
Sonoco
SON
$5.64B
$2.83M 0.03%
45,941
+14,046
+44% +$808K
TGT icon
183
Target
TGT
$66.8B
$2.79M 0.03%
34,799
+30,475
+705% +$2.23M
CBRL icon
184
Cracker Barrel
CBRL
$1.3B
$2.79M 0.03%
17,251
+4,720
+38% +$776K
VAC icon
185
Marriott Vacations Worldwide
VAC
$4.28B
$2.79M 0.03%
29,819
+1,279
+4% +$115K
PAHC icon
186
Phibro Animal Health
PAHC
$1.44B
$2.78M 0.03%
84,147
+2,343
+3% +$72.9K
DUK icon
187
Duke Energy
DUK
$96.6B
$2.77M 0.03%
30,752
+48
+0.2% +$4.23K
GPC icon
188
Genuine Parts
GPC
$18.3B
$2.76M 0.03%
24,662
-19,341
-44% -$2M
ATR icon
189
AptarGroup
ATR
$8.63B
$2.72M 0.03%
25,575
EFA icon
190
iShares MSCI EAFE ETF
EFA
$79.4B
$2.72M 0.02%
41,923
-11,289
-21% -$711K
KLAC icon
191
KLA
KLAC
$252B
$2.71M 0.02%
226,560
+72,040
+47% +$775K
EGOV
192
DELISTED
NIC Inc
EGOV
$2.71M 0.02%
158,350
-211,940
-57% -$3.36M
RDS.A
193
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.64M 0.02%
42,130
GWW icon
194
W.W. Grainger
GWW
$60.4B
$2.62M 0.02%
8,706
-1,793
-17% -$533K
HRC
195
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.61M 0.02%
24,670
RMAX icon
196
RE/MAX Holdings
RMAX
$230M
$2.54M 0.02%
65,994
+2,887
+5% +$111K
HEI icon
197
HEICO Corp
HEI
$50.8B
$2.37M 0.02%
24,955
-858
-3% -$74.8K
SLP icon
198
Simulations Plus
SLP
$371M
$2.37M 0.02%
112,044
+2,928
+3% +$58.6K
JOUT icon
199
Johnson Outdoors
JOUT
$498M
$2.28M 0.02%
31,934
+6,560
+26% +$429K
SJM icon
200
J.M. Smucker
SJM
$12.7B
$2.27M 0.02%
19,475
-2,635
-12% -$275K

Similar funds

Bahl & Gaynor's Q1 2019 Portfolio in Review

As of Q1 2019, Bahl & Gaynor held 358 positions worth $10.9B, up 17% from $9.35B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor deployed $431M of net new capital in Q1 2019, opening 19 new positions and adding to 175 existing holdings. Its largest new stake was Eaton: 47,492 shares worth $3.83M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AbbVie, an estimated $99.3M trimmed.

  • Bahl & Gaynor's largest Q1 2019 buy was Eaton: 47,492 shares worth $3.83M.
  • Bahl & Gaynor added most to Chevron in Q1 2019, an estimated $69.5M increase.
  • Bahl & Gaynor's biggest Q1 2019 reduction was AbbVie, cutting an estimated $99.3M.
  • Bahl & Gaynor fully exited Whirlpool in Q1 2019, selling an estimated $2.03M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $10.9B portfolio in Q1 2019.
  • Bahl & Gaynor opened 19 new positions and closed 11 in Q1 2019.
  • Bahl & Gaynor's portfolio value rose 17% quarter-over-quarter to $10.9B.

Based on Bahl & Gaynor's 13F filing for Q1 2019, filed 13 May 2019.